Cannabis executive salaries: who earned what in FY24 by Steve Jones October 16, 2024October 16, 2024 While the majority of Australia’s ASX-listed cannabis firms saw revenues climb in FY24, profitability often remained […]
Emyria in ‘final stages’ of winding down Emerald Clinics by Steve Jones September 3, 2024September 3, 2024
Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma by Steve Jones May 1, 2024May 1, 2024
Company news: Cann Compounding; Ecofibre; Ora Pharm; Althea; Melodiol Global Health; Wellnex Life; Emyria by Martin Lane and Steve Jones April 24, 2024November 25, 2024
Emyria inks deal to study MDMA-assisted therapy for first responders by Martin Lane April 3, 2024July 16, 2024
Company news: Zelira; ECS Botanics; LGP; Ecofibre; Neurotech; Elixinol; Emyria by Steve Jones and Martin Lane February 28, 2024July 16, 2024